Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Baoying Huang and Roujian Lu.
Baoying Huang
Connection Strength
0.747
Roujian Lu
  1. Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants. Chin Med J (Engl). 2021 Aug 16; 134(17):2048-2053.
    View in: PubMed
    Score: 0.241
  2. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 02 22; 395(10224):565-574.
    View in: PubMed
    Score: 0.216
  3. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):497-503.
    View in: PubMed
    Score: 0.061
  4. Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study. Virol Sin. 2021 10; 36(5):1088-1092.
    View in: PubMed
    Score: 0.060
  5. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 05 29; 6(1):212.
    View in: PubMed
    Score: 0.059
  6. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 07 28; 71(15):732-739.
    View in: PubMed
    Score: 0.056
  7. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 02 20; 382(8):727-733.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.